vs

Side-by-side financial comparison of Cardlytics, Inc. (CDLX) and Tempus AI, Inc. (TEM). Click either name above to swap in a different company.

Tempus AI, Inc. is the larger business by last-quarter revenue ($367.2M vs $50.9M, roughly 7.2× Cardlytics, Inc.). On growth, Tempus AI, Inc. posted the faster year-over-year revenue change (83.0% vs -25.5%). Cardlytics, Inc. produced more free cash flow last quarter ($13.0M vs $-41.5M). Over the past eight quarters, Tempus AI, Inc.'s revenue compounded faster (58.7% CAGR vs -9.6%).

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."

CDLX vs TEM — Head-to-Head

Bigger by revenue
TEM
TEM
7.2× larger
TEM
$367.2M
$50.9M
CDLX
Growing faster (revenue YoY)
TEM
TEM
+108.4% gap
TEM
83.0%
-25.5%
CDLX
More free cash flow
CDLX
CDLX
$54.5M more FCF
CDLX
$13.0M
$-41.5M
TEM
Faster 2-yr revenue CAGR
TEM
TEM
Annualised
TEM
58.7%
-9.6%
CDLX

Income Statement — Q4 2025 vs Q4 2025

Metric
CDLX
CDLX
TEM
TEM
Revenue
$50.9M
$367.2M
Net Profit
$-54.2M
Gross Margin
Operating Margin
-12.0%
-16.7%
Net Margin
-14.8%
Revenue YoY
-25.5%
83.0%
Net Profit YoY
-316.2%
EPS (diluted)
$-0.15
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDLX
CDLX
TEM
TEM
Q4 25
$50.9M
$367.2M
Q3 25
$47.0M
$334.2M
Q2 25
$58.0M
$314.6M
Q1 25
$56.4M
$255.7M
Q4 24
$68.3M
$200.7M
Q3 24
$61.1M
$180.9M
Q2 24
$64.0M
$166.0M
Q1 24
$62.2M
$145.8M
Net Profit
CDLX
CDLX
TEM
TEM
Q4 25
$-54.2M
Q3 25
$-72.7M
$-80.0M
Q2 25
$-9.3M
$-42.8M
Q1 25
$-13.3M
$-68.0M
Q4 24
$-13.0M
Q3 24
$-145.2M
$-75.8M
Q2 24
$-4.3M
$-552.2M
Q1 24
$-24.3M
$-64.7M
Operating Margin
CDLX
CDLX
TEM
TEM
Q4 25
-12.0%
-16.7%
Q3 25
-146.6%
-18.3%
Q2 25
-22.0%
-19.6%
Q1 25
-24.9%
-26.9%
Q4 24
-12.2%
-25.3%
Q3 24
-243.1%
-29.6%
Q2 24
-24.7%
-321.4%
Q1 24
-36.7%
-36.5%
Net Margin
CDLX
CDLX
TEM
TEM
Q4 25
-14.8%
Q3 25
-154.7%
-23.9%
Q2 25
-16.0%
-13.6%
Q1 25
-23.5%
-26.6%
Q4 24
-6.5%
Q3 24
-237.6%
-41.9%
Q2 24
-6.7%
-332.7%
Q1 24
-39.0%
-44.4%
EPS (diluted)
CDLX
CDLX
TEM
TEM
Q4 25
$-0.15
$-0.30
Q3 25
$-1.36
$-0.46
Q2 25
$-0.18
$-0.25
Q1 25
$-0.26
$-0.40
Q4 24
$-0.36
$2.56
Q3 24
$-2.90
$-0.46
Q2 24
$-0.09
$-6.86
Q1 24
$-0.56
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDLX
CDLX
TEM
TEM
Cash + ST InvestmentsLiquidity on hand
$48.7M
$604.8M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$-6.5M
$491.3M
Total Assets
$285.6M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDLX
CDLX
TEM
TEM
Q4 25
$48.7M
$604.8M
Q3 25
$44.0M
$655.9M
Q2 25
$46.7M
$186.3M
Q1 25
$52.0M
$151.6M
Q4 24
$65.6M
$341.0M
Q3 24
$67.0M
$388.0M
Q2 24
$71.2M
$478.8M
Q1 24
$97.8M
$79.9M
Total Debt
CDLX
CDLX
TEM
TEM
Q4 25
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$213.6M
Q3 24
$213.2M
Q2 24
$212.9M
Q1 24
$257.9M
Stockholders' Equity
CDLX
CDLX
TEM
TEM
Q4 25
$-6.5M
$491.3M
Q3 25
$-4.7M
$507.8M
Q2 25
$58.7M
$309.6M
Q1 25
$64.1M
$326.2M
Q4 24
$70.0M
$56.3M
Q3 24
$69.7M
$53.7M
Q2 24
$210.0M
$98.3M
Q1 24
$199.1M
$-1.5B
Total Assets
CDLX
CDLX
TEM
TEM
Q4 25
$285.6M
$2.3B
Q3 25
$292.8M
$2.3B
Q2 25
$361.1M
$1.6B
Q1 25
$369.1M
$1.5B
Q4 24
$392.7M
$926.1M
Q3 24
$399.4M
$971.7M
Q2 24
$534.4M
$864.6M
Q1 24
$569.0M
Debt / Equity
CDLX
CDLX
TEM
TEM
Q4 25
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
Q3 24
3.06×
Q2 24
1.01×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDLX
CDLX
TEM
TEM
Operating Cash FlowLast quarter
$13.0M
$-36.8M
Free Cash FlowOCF − Capex
$13.0M
$-41.5M
FCF MarginFCF / Revenue
25.5%
-11.3%
Capex IntensityCapex / Revenue
0.0%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M
$-239.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDLX
CDLX
TEM
TEM
Q4 25
$13.0M
$-36.8M
Q3 25
$1.8M
$-119.8M
Q2 25
$1.2M
$44.2M
Q1 25
$-6.7M
$-105.6M
Q4 24
$3.0M
Q3 24
$1.4M
$48.7M
Q2 24
$4.4M
$-97.1M
Q1 24
$-17.6M
$-101.4M
Free Cash Flow
CDLX
CDLX
TEM
TEM
Q4 25
$13.0M
$-41.5M
Q3 25
$1.7M
$-126.5M
Q2 25
$903.0K
$36.6M
Q1 25
$-6.8M
$-107.7M
Q4 24
$2.9M
Q3 24
$878.0K
$48.6M
Q2 24
$4.1M
$-105.1M
Q1 24
$-18.3M
$-107.5M
FCF Margin
CDLX
CDLX
TEM
TEM
Q4 25
25.5%
-11.3%
Q3 25
3.7%
-37.9%
Q2 25
1.6%
11.6%
Q1 25
-12.1%
-42.1%
Q4 24
4.2%
Q3 24
1.4%
26.9%
Q2 24
6.5%
-63.3%
Q1 24
-29.4%
-73.7%
Capex Intensity
CDLX
CDLX
TEM
TEM
Q4 25
0.0%
1.3%
Q3 25
0.0%
2.0%
Q2 25
0.6%
2.4%
Q1 25
0.2%
0.8%
Q4 24
0.2%
Q3 24
0.8%
0.0%
Q2 24
0.4%
4.8%
Q1 24
1.0%
4.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons